Literature DB >> 6307037

Certain progress in the treatment of coronary heart disease with traditional medicinal plants in China.

K J Chen.   

Abstract

A case of coronary heart disease in China was confirmed by the necropsy of a female body unearthed from the tomb at Changsha. It proved that such a case existed about 2,100 years ago. Research in reducing the frequency of myocardial infarction by traditional medicinal plants showed the effect of several herbs. The traditional aromatic and warm herbal medicines may have the possibility of relieving coronary arterial spasm. The clinical and experimental observations proved that the Huoxue-huayu plants' action against blood platelet aggregation and against attack was effective.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6307037     DOI: 10.1142/s0192415x81000251

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  5 in total

1.  Common glory: the traditional and the contemporary-complementary nature of Chinese and modern medicine--a speech at Nobel laureate summit and academician forum of medicine (2014).

Authors:  Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2015-11-03       Impact factor: 1.978

2.  Development track of the modern activating blood circulation and removing stasis (ABCRS) school on inheritance and innovation.

Authors:  Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2015-12-03       Impact factor: 1.978

3.  Effect of Danshen aqueous extract on serum hs-CRP, IL-8, IL-10, TNF-α levels, and IL-10 mRNA, TNF-α mRNA expression levels, cerebral TGF-β1 positive expression level and its neuroprotective mechanisms in CIR rats.

Authors:  Xue-Yun Liang; Hai-Ning Li; Xiao-Yan Yang; Wen-Yan Zhou; Jian-Guo Niu; Ben-Dong Chen
Journal:  Mol Biol Rep       Date:  2013-02-02       Impact factor: 2.316

4.  The Relationship between Traditional Chinese Medicine and Modern Medicine.

Authors:  Jingcheng Dong
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-30       Impact factor: 2.629

5.  In silico Approach for Anti-Thrombosis Drug Discovery: P2Y1R Structure-Based TCMs Screening.

Authors:  Fan Yi; Le Sun; Li-Jia Xu; Yong Peng; Hai-Bo Liu; Chun-Nian He; Pei-Gen Xiao
Journal:  Front Pharmacol       Date:  2017-01-09       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.